Skip to main content
Download PDF

Pretreatment of nucleus pulposus mesenchymal stem cells with appropriate concentration of H2O2 enhances their ability to treat intervertebral disc degeneration

Stem Cell Research & Therapy volume 13, Article number: 340 (2022) Cite this article

Abstract

Background

Nucleus pulposus mesenchymal stem cells (NPMSCs) transplantation is a promising treatment for intervertebral disc degeneration (IVDD). However, the transplanted NPMSCs exhibited weak cell proliferation, high cell apoptosis, and a low ability to resist the harsh microenvironment of the degenerated intervertebral disc. There is an urgent need to explore feasible methods to enhance the therapeutic efficacy of NPMSCs transplantation.

Objective

To identify the optimal concentration for NPMSCs pretreatment with hydrogen peroxide (H2O2) and explore the therapeutic efficacy of NPMSCs transplantation using H2O2 pretreatment in IVDD.

Methods

Rat NPMSCs were pretreated with different concentrations (range from 25 to 300 μM) of H2O2. The proliferation, reactive oxygen species (ROS) level, and apoptosis of NPMSCs were detected by cell counting kit-8 (CCK-8) assay, 5-ethynyl-2′-deoxyuridine (EdU) staining, and flow cytometry in vitro. The underlying signalling pathways were explored utilizing Western blotting. A rat needle puncture-stimulated IVDD model was established. X-ray, histological staining, and a multimode small animal live imaging system were used to evaluate the therapeutic effect of H2O2-pretreated NPMSCs in vivo.

Results

NPMSCs pretreated with 75 μM H2O2 demonstrated the strongest elevated cell proliferation by inhibiting the Hippo pathway (P < 0.01). Meanwhile, 75 μM H2O2-pretreated NPMSCs exhibited significantly enhanced antioxidative stress ability (P < 0.01), which is related to downregulated Brd4 and Keap1 and upregulated Nrf2. NPMSCs pretreated with 75 μM H2O2 also exhibited distinctly decreased apoptosis (P < 0.01). In vivo experiments verified that 75 μM H2O2-pretreated NPMSCs-transplanted rats exhibited an enhanced disc height index (DHI% = 90.00 ± 4.55, P < 0.01) and better histological morphology (histological score = 13.5 ± 0.5, P < 0.01), which means 75 μM H2O2-pretreated NPMSCs can better adapt to the environment of degenerative intervertebral discs and promote the repair of IVDD.

Conclusions

Pretreatment with 75 μM H2O2 was the optimal concentration to improve the proliferation, antioxidative stress, and antiapoptotic ability of transplanted NPMSCs, which is expected to provide a new feasible method to improve the stem cell therapy efficacy of IVDD.

Introduction

IVDD is an important cause of low back pain (LBP) and lower extremity dysfunction, which impose a heavy economic burden on society [1, 2]. The intervertebral disc is an important connection structure between the vertebral bodies that consists of the nucleus pulposus, the annulus fibrosus, and the upper and lower cartilage endplates, which can maintain the amplitude of spinal motion and withstand mechanical pressure [3]. When the intervertebral disc undergoes gradual degeneration, the number of nucleus pulposus cells and the anabolic processes decrease, resulting in a series of clinical symptoms, such as backache, numbness, and lower limb pain [4]. Although surgery is a commonly chosen method for palliating symptoms, surgery fails to restore the biological and mechanical functions of the intervertebral disc and may even alter the biomechanical function of the spine, which may lead to further degeneration of the adjacent intervertebral disc [5, 6]. Therefore, it is necessary to explore new feasible strategies to treat IVDD.

Stem cell transplantation has become a promising therapeutic method utilized to treat IVDD experimentally and clinically in recent years [7, 8]. The intervertebral disc is recognized as an immune-exempt area, and this feature makes it possible to use exogenous stem cells to treat IVDD [9, 10]. Extensive studies have shown that a variety of stem cells can directly differentiate into nucleus pulposus cells and facilitate the function of degenerative nucleus pulposus cells in a paracrine manner when transplanted into the degenerative intervertebral disc [11,12,13,14]. Recent studies have identified NPMSCs with mesenchymal stem cell characteristics in the nucleus pulposus tissue, which possess a stronger ability to differentiate into nucleus pulposus cells and withstand the microenvironment of the intervertebral disc compared with commonly used stem cells such as bone marrow mesenchymal stem cells (BMMSCs) and adipose mesenchymal stem cells (ADMSCs) [15,16,17]. However, the low viability of transplanted stem cells at the transplant site has become a bottleneck for stem cell-based IVDD therapy. The intervertebral disc is the largest tissue without blood supply in the whole body, and the degenerated intervertebral disc exhibits a harsh microenvironment with low nutrition, low pH, high mechanical pressure, and high osmotic pressure, coupled with distinct oxidative stress and local inflammation. Therefore, the transplanted cells will suffer cell cycle arrest and considerable cell death, which immensely undermine the effect of stem cell transplantation and even lead to transplantation failure [18,19,20].

Numerous methods have been explored to improve the therapeutic effect of transplanted stem cells in IVDD treatment, including conjunction with biological scaffolds, hydrogel materials, genetic modification, and cellular pretreatment, and pretreatment of stem cells with the mimetic harsh environment (e.g., hypoxia, acid, mechanical intervention) can improve their postengraftment survival and differentiation characteristics [21,22,23]. Among these pretreatments, pretreatment of transplanted cells with H2O2 is convenient to obtain and simple to perform. Previous studies have shown that pretreatment with an appropriate concentration of H2O2 can significantly improve the proliferation, paracrine manner, antiapoptotic ability, and therapeutic effect of MSCs in liver fibrosis, skin wounds, and myocardial infarction [24,25,26]. However, a high concentration of H2O2 is cytotoxic and will cause an increase in ROS, which may lead to irreversible oxidative damage to the cells [27, 28].

Based on the above studies, we hypothesized that NPMSCs pretreated with an appropriate concentration of H2O2 may have better biological functions, such as proliferation and antiapoptosis, and may be suitable for stem cell transplantation-based intervertebral disc repair. Therefore, this study aims to verify the optimal concentration of H2O2 pretreatment and explore whether pretreated NPMSCs possess presumptive therapeutic effects in treating intervertebral disc degeneration.

Materials and methods

Ethical statement

Animal experiments were performed on 8-week-old male Sprague Dawley (SD) rats (n = 72) provided by the Animal Center of Xinqiao Hospital. NPMSCs were extracted from 30 rats, and 42 rats were used for the cell transplantation experiments. All experiments were approved by the Ethics Committee of the Army Medical University.

Experimental design and treatment protocol

In vitro: After isolating NPMSCs, we identified the trilineage differentiation capacity (n = 3) and detected the characteristic cell surface molecules of mesenchymal stem cells (n = 3). The cells were treated with different concentrations of H2O2 (ranging from 25 to 300 μM), and then cell counting kit-8 (CCK-8) assay experiments (n = 3), EdU experiments (n = 3), and Western blotting (n = 3) were used to explore the optimal concentration of H2O2 and the possible mechanism to promote the proliferation of NPMSCs. Next, NPMSCs pretreated with the optimal concentration of H2O2 were exposed to a sublethal dose of H2O2. Then, intracellular reactive oxygen species (ROS) were detected by a dichlorodifluorofluorescein diacetate (DCFH-DA) probe (n = 3), mitochondrial membrane potential (MMP) was detected by a CMXRos probe (n = 3), the percentage of apoptosis was detected by an Annexin V-PE/7-AAD probe (n = 3), and Western blotting (n = 3) was used to explore the possible mechanism. A schematic depiction of the treatment timelines is presented in Additional file 1: Fig. S1.

In vivo: Rats with intervertebral disc degeneration were randomly divided into the following groups: (1) untreated group (n = 6); (2) phosphate-buffered saline (PBS) injection group (n = 6); (3) NPMSCs group (n = 6); (4) 50 μM H2O2-pretreated NPMSCs group (n = 6); (5) 75 μM H2O2-pretreated NPMSCs group (n = 6); and (6) 100 μM H2O2-pretreated NPMSCs group (n = 6). The NPMSCs were labelled with green fluorescent protein (GFP), and X-rays were taken before treatment and on the 30th and 60th days after treatment, and the change in DHI% was calculated. The fluorescence intensity (n = 3) and histological changes in the intervertebral disc were detected on the 60th day after treatment. A schematic depiction of the timelines is presented in Fig. 6a.

Cell preparation

Rats were killed after being properly anaesthetized with 2% pentobarbital (50 mg/kg), and then the caudal vertebrae were isolated after removing the skin, ligaments, and muscle tissues under aseptic conditions. The nucleus pulposus tissue was separated from the caudal intervertebral disc, and then we mixed the nucleus pulposus tissue of every 10 rats and digested it with 0.2% type II collagenase (C2-BIOC, Sigma-Aldrich, USA) for approximately 2 h at 37 °C, followed by centrifugation at 400×g for 5 min at room temperature. The supernatant was discarded and the sediment was suspended and cultured in a standard mesenchymal stem cell growth medium, consisting of Dulbecco modified Eagle medium low glucose (SH30021, HyClone, Logan, USA), 10% foetal calf serum (S711-001S, LONSA, Canelones, UY), and 1% penicillin/streptomycin (C0222, Beyotime, Shanghai, China). NPMSCs were placed in a humidified chamber in a 5% CO2–air mixture at 37 °C. The medium was changed every 3–4 days. Cells were subcultured when they reached a confluence of 80–90%. NPMSCs from the third generation were used throughout the experiment.

Detection of cell surface markers

NPMSCs were digested with 0.25% trypsin (SH30042, HyClone) and suspended in PBS at 5 × 105 cells/ml. Furthermore, 100 µl of cell suspension solution was aliquoted per tube and incubated, respectively, with a solution of fluorescein isothiocyanate (FITC)-conjugated CD34, CD45, CD73, CD90, and CD105 (all from Bioworld, MN, USA) at room temperature for 30 min. An isotype control was used in each case. After incubation, the cells were washed three times with PBS and then centrifuged at 4 °C at 250×g for 5 min. The supernatant was discarded, and the cells were resuspended in 500 µl of PBS prior to flow cytometry analyses (Gallios, Beckman, Germany).

Detection of multilineage differentiation ability

The multilineage differentiation ability of NPMSCs was detected using an osteogenic differentiation induction kit (RASMX-90021, Cyagen Biosciences, Suzhou, China), a chondrogenic differentiation induction kit (RASMX-90041/90042, Cyagen Biosciences), and an adipogenic induction differentiation kit (RASMX-90031, Cyagen Biosciences). After 21 days of induction, NPMSCs were fixed with 4% paraformaldehyde (P0099, Beyotime) for 30 min. Then, Alizarin Red staining, Oil Red O staining, and Alcian Blue staining were performed according to the instructions.

Cell counting kit-8 assay

The cell viability of the NPMSCs was detected using cell counting kit-8 (C0038, Beyotime). NPMSCs were seeded into 96-well plates at a density of 5 × 103 cells. NPMSCs were able to grow adherent cells in the plates after one night of culture. Then, H2O2 (323381, Sigma-Aldrich) was added to the medium for 12 h at concentrations of 25, 50, 75, 100, 150, 200, and 300 μM. The medium was replaced with fresh medium. Then, 10 µl CCK‐8 reagent was added to each well and incubated at 37 °C for 2 h. A spectrophotometer (M2, MOLECULAR DEVICE, USA) was used to detect the optical density (OD) values at a wavelength of 450 nm. Each trial was repeated three times.

EdU staining assay

Cell proliferation activity was detected using an EdU-555 cell proliferation detection kit (C0075S, Beyotime). The cells were inoculated into 6-well plates at a density of 2 × 105 cells per well. The cells were then treated with H2O2 at concentrations of 25, 50, 75, 100, 150, 200, and 300 μM for 12 h. Meanwhile, we designed four treatment methods for further exploration: untreated group, 75 μM H2O2 treatment for 12 h, 300 μM H2O2 treatment for 12 h, 75 μM H2O2 treatment for 12 h and then 300 μM H2O2 treatment for 12 h. Two millilitres of 10 μM EdU reagent was added to each well and incubated for 2 h. Cells were fixed at room temperature for 15 min with 2 ml 4% paraformaldehyde. Two millilitres of immunostaining strong permeability solution (P0097, Beyotime) was added to each well and incubated for 15 min. Two millilitres of Click Additive Solution was added to each well and incubated for 30 min at room temperature (shielded from light). The nuclei were stained with Hoechst 33,358 solution (C0021, Solarbio, Beijing, China). Immunofluorescent staining images were captured by a fluorescence microscope (IX73, Olympus, Tokyo, Japan).

Western blotting

Protein was extracted from NPMSCs by a radioimmunoprecipitation assay (RIPA) solution (P0013B, Beyotime) containing 2% phenylmethanesulfonyl fluoride (PMSF) (ST507, Beyotime) and 2% phosphatase inhibitor (P1082, Beyotime). The protein was then centrifuged at 4 °C and 12,000×g for 5 min to collect the supernatant. Protein concentration was detected by bicinchoninic acid (BCA) protein concentration assay kit (PC0020, Solarbio). Then, protein loading buffer (P0015L, Beyotime) was added to each sample and heated in a boiling water bath for 5 min. The protein was separated in a 12% sodium salt-polyacrylamide gel, and then the protein was transferred to polyvinylidene fluoride (PVDF) membranes (ISEQ00010, Merck Millipore, Darmstadt, Germany). The membranes were soaked with 5% skim milk powder (P0216, Beyotime) for 1 h at room temperature and incubated with corresponding antibodies at 4 °C overnight. After washing with tris-buffered saline (TBS) with Tween-20 (TBST), the membranes were immersed in the corresponding horseradish peroxidase-labelled secondary antibody (diluted concentration 1:500) and incubated at room temperature for 1 h. An electrochemiluminescence (ECL) kit (1705060, BIO-RAD, CA, USA) and a gel imaging system (ChemiDoc, Bio-Rad) were utilized to visualize the protein content. Protein bands were analysed using ImageJ software (National Institute of Health, USA). All results were quantified and normalized to β-actin. The antibodies used were as follows: cyclin D1 (ab134175), P16 (ab51243), β-actin (ab8227), cytochrome C (ab133504), Brd4 (ab75898), Keap1 (ab119403), and Nrf2 (ab92946) from Abcam (Cambridge, UK); cleaved caspase-3 (9664T), p-Lats1 (9157), p-Mst1 (49332), p-YAP (13008T), and YAP (14074T) from CST (Shanghai, China). Bcl-2 (26593-1-AP) and Bax (60267-1-Ig) were purchased from Proteintech (Chicago, USA).

Detection of ROS

ROS levels in cells were detected using an ROS detection kit (S0033M, Beyotime). Two millilitres of 10 μM DCFH-DA (diluted in serum-free medium) was added to each well, and the cells were incubated at 37 °C for 20 min (shielded from light). The cells were then washed with serum-free medium three times to remove the unloaded probes. Then, the cells were collected and the production of ROS was detected by flow cytometry.

Detection of MMP

MitoTracker Red CMXRos (C1049B, Beyotime) was used to detect MMP. Briefly, NPMSCs were inoculated into 6-well plates at a density of 2 × 105 cells per well and treated with H2O2 at concentrations of 75 and 300 μM for 24 h, with or without 75 μM H2O2 for 12 h prior to 300 μM H2O2 treatment. Then, 1 ml of MitoTracker Red CMXRos working solution was added to each well and incubated at 37 °C for 30 min (shielded from light). The nuclei were stained with Hoechst 33,358 staining solution. The staining was observed under a laser confocal microscope (LSM880, ZEISS, Germany).

Detection of apoptosis rate

The rate of apoptosis was detected using the Annexin VPE/7-AAD apoptosis detection kit (BD Pharmingen, Franklin Lakes, NJ, USA). NPMSCs were collected and resuspended in binding buffer at a concentration of 5 × 106 cells/ml. Then, 100 µl of cell suspension was transferred to the test tube, and 5 µl of Annexin VPE and 5 µl of 7-AAD were added. After incubating at room temperature for 15 min (shielded from light), 400 µl binding buffer was added to each sample and the apoptosis rate was detected by flow cytometry.

Labelling NPMSCs with green fluorescent protein (GFP)

Lentiviral vectors expressing GFP (GV493, GeneChem, Shanghai, China) were transfected into NPMSCs according to the manufacturer’s instructions. The multiplicity of infection (MOI) was set at 20, and the transfection time was set at 18 h. Puromycin (5 μg/ml, ST551, Beyotime) was used to select stably transfected NPMSCs.

Establishment of IVDD model in rats

Forty-two healthy male SD rats aged 8 weeks were randomly selected for animal experiments. Rats were fasted for 12 h before surgery, and water was forbidden for 4 h before surgery. Then, the rats were anaesthetized by intraperitoneal injection of 2% pentobarbital (50 mg/kg). The tail skin of rats was sterilized three times with iodophor, and percutaneous intervertebral disc puncture was performed with a no. 20 needle at the coccyx 6–7 (CO6-7) level [29]. The needle was vertically inserted at a depth of 5 mm and rotated 360° for 30 s before exiting. The surgical areas were then sterilized again with iodophor. Rats were provided with food and water 12 h after the operation to prevent intestinal paralysis.

NPMSCs transplantation in IVDD rats

Thirty days after the operation, X-ray was used to verify whether IVDD was successfully created. After excluding 3 rats that died accidentally and 3 rats that failed to induce IVDD, the remaining 36 rats with obvious IVDD were randomly divided into 6 groups with different treatments at CO6-7: Untreated group were treated without any treatment, PBS injection group were injected with 2 µl PBS, NPMSCs group were injected with labelled NPMSCs (5 × 104 cells, suspended in PBS), 50 μM H2O2 pretreated NPMSCs group were injected with labelled NPMSCs (5 × 104cells, suspended in PBS) after 50 μM H2O2 pretreatment for 12 h, 75 μM H2O2 pretreated NPMSCs group were injected with labelled NPMSCs (5 × 104 cells, suspended in PBS) after 75 μM H2O2 pretreatment for 12 h, and 100 μM H2O2-pretreated NPMSCs group were injected with labelled NPMSCs (5 × 104 cells, suspended in PBS) after 100 μM H2O2 pretreatment for 12 h. PBS and cells were injected through a microsyringe (25 µl, Gaoge, Shanghai, China).

Disc height measurement

A multimode small animal live imaging system (Xtreme ll, Bruker, Belgium) was used to obtain X-ray images of rats. Rats were anaesthetized by intraperitoneal injection of 2% pentobarbital (50 mg/kg). Then, the rats were fixed on the tray and put into the apparatus. The parameters were as follows: Modality (X-Ray), Background (None), Illumination (X-Ray), Filters (X-Ray 0.4 mm, KVP 45, Excitation 0, Emission 0), Exposure time (1.2 s), FOV (15CM), fStop (2), Bin (1 × 1), Focal Plane (0 mm), and Focal Zone (X-Ray). Finally, ImageJ was used to measure the three longitudinal lines of the intervertebral disc and the two adjacent upper and lower vertebral bodies, and then the DHI% was calculated according to the method recorded in previous research [9] to evaluate the degree of intervertebral disc degeneration.

Histological analyses of the caudal intervertebral disc

On the 60th day after treatment, the caudal vertebrae of the rats were collected. The samples were fixed in 4% paraformaldehyde solution for 48 h. Then, rapid bone tissue decalcification solution (BB-23619, BestBio, Shanghai, China) was used for 2 days of decalcification. Then, the samples were dehydrated with ethanol solutions of different concentrations (75%, 85%, 95%, and 100%). Paraffin sections (6 um) were prepared and stained with Haematoxylin–Eosin (HE) Staining Kit (G1120, Solarbio) and a Modified Safranine O-Fast Green FCF Stain Kit (G1371, Solarbio) to evaluate the degree of IVDD in each group. Three observers blindly observed the shape and structure of the intervertebral disc and the type and number of cells in the intervertebral disc and scored them using the grading scale (Additional file 2: Table S1) reported in previous research [30].

Fluorescence imaging of rats in vivo

A multimode small animal live imaging system (Xtreme ll, Bruker) was used to obtain fluorescence images of rats. Rats were anaesthetized by intraperitoneal injection of 2% pentobarbital (50 mg/kg). Then, we fixed the rats on the tray and placed them into the apparatus. The parameters were as follows: Modality (Fluorescence), Background (None), Illumination (Multi-wavelength), Filters (X-Ray 0 mm, KVP 45, Excitation 470, Emission 535), Exposure time (2 s), FOV (15CM), fStop (2), Bin (2 × 2), Focal Plane (0 mm), and Focal Zone (Tray).

Statistical analysis

All experiments were repeated three times with at least triplicate samples. The results are presented as the mean ± standard deviation (SD). Statistical analysis was performed using SPSS 23.0 (SPSS Inc. IL, New York, NY, USA). Multiple comparisons were made using one-way or two-way analysis of variance (ANOVA) followed by Bonferroni’s post hoc test. The DHI% data were analysed by two-way repeated-measures ANOVA followed by Bonferroni’s post hoc test. A value of P < 0.05 was considered statistically significant.

Results

Identification of NPMSCs

NPMSCs were isolated from the rat caudal intervertebral disc. After 5 days of culture, the primary cells exhibited a short spindle shape. The third generation of NPMSCs showed accelerated and spiral cell growth (Fig. 1a).

Fig. 1
figure 1

Identification of NPMSCs. a Representative image illustrating the morphology of NPMSCs. Scale bar = 200 μm. b Alizarin Red staining, Alcian Blue staining, and Oil Red O staining results of NPMSCs at 21 days post-induction. Scale bar = 50 μm. c Flow cytometry examining the expression of CD34, CD45, CD73, CD90, and CD105 on NPMSCs

Full size image

The multilineage differentiation ability of NPMSCs was assessed in the third generation of NPMSCs. After induction for 21 days, Alizarin Red staining showed the formation of mineralized nodules after osteogenic differentiation induction. Alcian Blue staining showed distinct sulphurated proteoglycan staining after chondrogenic differentiation induction. Oil Red O staining showed lipid vacuole formation after adipogenic differentiation induction (Fig. 1b). Flow cytometry results showed that the expression of CD73, CD90, and CD105 was positive (more than 95%) and CD34and CD45 were negative (less than 5%) in NPMSCs (Fig. 1c).

H2O2 (75 μM) promoted the proliferation of NPMSCs by inhibiting the Hippo signalling pathway

CCK-8 experiments showed that 75 μM and 100 μM H2O2 treatments could significantly improve the proliferation of NPMSCs (OD = 1.76 ± 0.04 P < 0.01; OD = 1.37 ± 0.01 P < 0.01), whereas 300 μM H2O2 dramatically inhibited the proliferation ability of NPMSCs (OD = 0.20 ± 0.05 P < 0.01) (Fig. 2a). The results of EdU staining showed that compared to the 0 μM H2O2 group (12.2% ± 1.8%), after 75 μM H2O2 treatment, the percentage of EdU-positive cells increased to 33. 0% ± 1.9% (P < 0.01), while 300 μM H2O2 reduced the percentage of EdU-positive cells to 5.7% ± 1.2% (P < 0.01) (Fig. 2b, c). Western blot results showed that 75 μM H2O2 treatment elevated the expression of cyclin D1 and suppressed the expression of cyclin-dependent kinase inhibitor 2A (P16) (P < 0.01). In comparison, 300 μM H2O2 treatment significantly inhibited the expression of cyclin D1 and significantly increased the expression of P16 (P < 0.01) (Fig. 2d, e).

Fig. 2
figure 2

Effects of different H2O2 concentrations on NPMSCs proliferation. a The effect of H2O2 on NPMSC proliferation detected by the CCK-8 assay. (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test). b and c Detection of proliferated NPMSCs (red) under different H2O2 concentrations by the EdU-555 proliferation assay kit and quantification. Nuclei were counterstained with Hoechst 33358 (blue) (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test). Scale bar = 200 μm. d and e Western blotting analysis of cyclin D1 and P16 expression in NPMSCs exposed to different concentrations of H2O2 for 12 h (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test). f and g Western blotting analysis of p-Lats1, p-Mst1, p-YAP, and YAP expressions in NPMSCs exposed to different concentrations of H2O2 for 12 h (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test)

Full size image

Western blotting was used to detect the expression of key proteins in the Hippo pathway. The results showed that 75 μM H2O2 treatment reduced the phosphorylation levels of key proteins in the Hippo pathway including phosphorylated large tumour suppressor kinase 1 (p-Mst 1) (P < 0.01), phosphorylated mercaptopyruvate sulfurtransferase-1 (p-Lats1) (P < 0.05), and phosphorylated Yes1-associated transcriptional regulator (p-YAP) (P < 0.01) (Fig. 2f, g). However, NPMSCs that received 300 μM H2O2 treatment exhibited the opposite result.

Pretreatment with 75 μM H2O2 enhanced the antioxidative stress capacity of NPMSCs

The intracellular ROS content was detected under different concentrations of H2O2 treatment by flow cytometry. In the pretreatment process, we found that with increasing H2O2 concentration, the intracellular ROS concentration also increased (Fig. 3a, b). However, compared with the 300 μM H2O2 group (59.8% ± 4.4%), NPMSCs that received 75 μM H2O2 pretreatment for 12 h showed significantly lower ROS content when they were exposed to 300 μM H2O2 again (20.4% ± 2.5% P < 0.01) (Fig. 3c, d).

Fig. 3
figure 3

Effect of different H2O2 concentrations on ROS and MMP in NPMSCs. a and b The intracellular ROS in NPMSCs that received different H2O2 concentrations were detected by flow cytometry and quantified (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test). c and d The intracellular ROS in NPMSCs that received 75 μM H2O2 pretreatment were detected by flow cytometry and quantified (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test). e and f The MMP of NPMSCs received 75 μM H2O2 pretreatment detected by CMXRos and quantified (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test, ##P < 0.01 compared to the 300 μM H2O2 group). Scale bar = 50 μm

Full size image

The MitoTracker Red CMXRos probe was used to detect the MMP. The results showed that the mean fluorescence intensity of CMXRos in NPMSCs treated with 300 μM H2O2 was significantly reduced (17.6 ± 2.4 P < 0.01). However, after pretreatment with 75 μM H2O2, the mean fluorescence intensity of cells was higher than the mean fluorescence intensity of cells treated with 300 μM H2O2 alone (55.1 ± 10.4 P < 0.01) (Fig. 3e, f).

Pretreatment with 75 μM H2O2 improved the resistance of NPMSCs to oxidative stress by inhibiting Brd4 and activating the Keap1-Nrf2 signalling pathway

We detected the expression of key proteins in the Keap1-Nrf2 signalling pathway. Western blotting results showed that when NPMSCs pretreated with 75 μM H2O2 were exposed to 300 μM H2O2, the expression level of Keap1 declined significantly (P < 0.01), and the expression level of Nrf2 dramatically rose compared to NPMSCs exposed to 300 μM H2O2 alone (P < 0.01) (Fig. 4a, b).

Fig. 4
figure 4

Effect of different H2O2 concentrations on the Keap1-Nrf2 signalling pathway in NPMSCs. a and b Western blotting analysis of Keap1 and Nrf2 expression in NPMSCs exposed to different concentrations of H2O2 (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test. #P < 0.05 compared to the 300 μM H2O2 group). c and d Western blotting analysis of Brd4 expression in NPMSCs exposed to different concentrations of H2O2 (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test. #P < 0.01 compared to the 300 μM H2O2 group). e and f Western blotting analysis estimating the effect of 75 μM H2O2 pretreatment on Keap1, Nrf2, and Brd4 expression and quantification when NPMSCs were subsequently exposed to 300 μM H2O2 (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test. ##P < 0.01 compared to the 300 μM H2O2 group)

Full size image

We found that compared with exposure to 300 μM H2O2 alone, Brd4 expression in NPMSCs pretreated with 75 μM H2O2 decreased significantly when the NPMSCs were exposed to 300 μM H2O2 (P < 0.01) (Fig. 4c, d). Furthermore, we treated 75 μM H2O2-pretreated NPMSCs with the Brd4 inhibitor JQ-1 (13030, MCE, Shanghai, China) and then exposed the cells to 300 μM H2O2. Western blotting results showed that Brd4 expression in cells in the JQ-1 treatment group and 75 μM H2O2 pretreatment group decreased tremendously (P < 0.01). Meanwhile, the expression level of Keap1 was significantly decreased and the expression level of Nrf 2 was significantly elevated (P < 0.01) (Fig. 4e, f).

Pretreatment with 75 μM H2O2 enhanced the antiapoptotic capacity of NPMSCs

The results of flow cytometry showed that when the treatment concentration of H2O2 was less than 150 μM, there was no statistically significant change in the percentage of apoptotic NPMSCs. The percentage of apoptosis increased when NPMSCs were treated with 200 μM (29.8% ± 3.9%, P < 0.01) and 300 μM (44.1% ± 2.2%, P < 0.01) H2O2 (Fig. 5a, b). However, when NPMSCs were pretreated with 75 μM H2O2 for 12 h, the percentage of apoptotic cells was significantly reduced (8.71% ± 1.44% P < 0.01) when they were subsequently exposed to 300 μM H2O2 (Fig. 5c, d).

Fig. 5
figure 5

Effect of different H2O2 concentrations on the antiapoptotic capacity of NPMSCs. a and b Effect of different H2O2 concentrations on the apoptosis ratio detected by flow cytometry and quantification (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test). c and d Effect of 75 μM H2O2 pretreatment on the apoptosis ratio detected by flow cytometry and quantification when NPMSCs were subsequently exposed to 300 μM H2O2 (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test. ##P < 0.01 compared to the 300 μM H2O2 group). e and f Western blotting analysis estimating the effect of different H2O2 concentrations on Bcl-2, Bax, cleaved caspase-3, and cytochrome C expression and quantification (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test). g and h Western blotting analysis estimating the effect of 75 μM H2O2 pretreatment on Bcl-2, Bax, cleaved caspase-3, and cytochrome C expression and quantification when NPMSCs were subsequently exposed to 300 μM H2O2 (n = 3, *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test. #P < 0.05, ##P < 0.01 compared to the 300 μM H2O2 group)

Full size image

We examined the effects of different concentrations of H2O2 on mitochondrial apoptosis-related proteins. The results showed that 75 μM H2O2 treatment exhibited the highest ratio of Bcl-2 to Bax (P < 0.01). Over 100 μM H2O2 led to distinctly increased cytochrome C levels. Increased cleaved caspase-3 levels were observed when the concentrations of H2O2 exceeded 150 μM (Fig. 5e, f). However, compared with NPMSCs treated with 300 μM H2O2-treated NPMSCs, NPMSCs pretreated with 75 μM H2O2 demonstrated an elevated Bcl-2/Bax ratio (P < 0.05), decreased cleaved caspase-3 (P < 0.05) and suppressed cytochrome C (P < 0.01) when they were subsequently exposed to 300 μM H2O2 (Fig. 5g, h). The overall in vitro experimental flow chart and timetable are shown in Additional file 1: Fig. S1.

Pretreatment with 75 μM H2O2 promoted the therapeutic effects of transplanted NPMSCs in treating IVDD

The overall in vivo experimental flow chart and timetable are shown in Fig. 6a. First, we established rat models of IVDD. Then, the GFP was successfully overexpressed in NPMSCs to trace the transplanted cells (Fig. 6b). Next, NPMSCs pretreated with 50 μM, 75 μM, or 100 μM H2O2 were injected into degenerative intervertebral discs, and X-rays were taken on the 30th and 60th days after transplantation (Fig. 6d, e). The DHI% of rat caudal intervertebral disc was calculated according to a previously reported calculation method [10] (Fig. 6c). On the 60th day after transplantation, we found that all groups with cell transplantation showed an increase in DHI% compared to the untreated group (DHI% = 49.00 ± 1.52) and PBS injection group (DHI% = 46.57 ± 4.00). The treatment effect of the 75 μM H2O2-pretreated NPMSCs group (DHI% = 90.00 ± 4.55 P < 0.01) was better than the treatment effect of the NPMSCs group (DHI% = 69.51 ± 3.31), 50 μM H2O2-pretreated NPMSCs group (DHI% = 74.85 ± 1.89) and 100 μM H2O2-pretreated NPMSCs group (DHI% = 74.12 ± 2.16) (Fig. 6d–f).

Fig. 6
figure 6

Pretreatment with 75 μM H2O2 facilitated the therapeutic effects of transplanted NPMSCs in treating IVDD. a Flow chart and timetable of rat treatment from day 0 to day 90. b GFP was overexpressed in NPMSCs utilizing lentiviral vectors to trace the transplanted cells. Scale bar = 200 μm. b Representative X-ray images were taken on the 0, 30th, and 60th days after injection. c Methods of calculating DHI%. d–f Quantification of DHI% in rats on designated days after treatment. (n = 6, two-way repeated-measures ANOVA followed by Bonferroni’s post hoc test. *P < 0.05, **P < 0.01). g and h On the 60th day after treatment, the fluorescence intensity of GFP-labelled NPMSCs in intervertebral discs was detected by the multimode small animal live imaging system (n = 3, one-way ANOVA followed by Bonferroni’s post hoc test). i Representative HE staining and Safranine O-Fast Green staining illustrating the histological structure of the NP tissue at 60 days after treatment. Scale bar = 500 μm. j Histological score of the intervertebral disc in each group (n = 3, one-way ANOVA followed by Bonferroni’s post hoc test. P < 0.05, **P < 0.01, ns no statistical difference)

Full size image

In vivo fluorescence imaging results showed that obvious fluorescence could be observed in the caudal intervertebral disc of all groups of rats transplanted with NPMSCs. The fluorescence intensity of the rats injected with NPMSCs pretreated with 75 μM H2O2 was higher than the fluorescence intensity of the 50 μM H2O2-pretreated NPMSCs group and 100 μM H2O2-pretreated NPMSCs group (P < 0.05) and NPMSCs group (P < 0.01) (Fig. 6g, h).

The histological structure of the NP tissue on the 60th day after transplantation was analysed by HE staining, Safranine O-Fast Green staining, and histological scores of IVDD (Fig. 6i, j). Reduced disc contents and disordered fibrous tissue were observed in the untreated group and the PBS group. Compared to the untreated group, the histological scores of the four cell transplantation groups were higher, while compared with the NPMSCs group (9.67 ± 0.33), the 75 μM H2O2-pretreated NPMSCs group exhibited the optimal ameliorative outcome (10.33 ± 0.33 P < 0.01).

Discussion

Although many studies have reported that stem cell transplantation is a feasible method in the treatment of IVDD, the insufficient efficiency of transplantation and low survival rate of grafts limit the therapeutic potential of this method to some extent [13, 31]. A high concentration of H2O2 can induce a surge in intracellular ROS, which damages organelles and results in cell cycle arrest and cell apoptosis [27]. However, pretreatment of transplanted cells with H2O2 at appropriate concentrations can result in beneficial effects. For example, pretreatment with H2O2 enhanced the antiapoptotic ability of BMMSCs in skin wounds [24, 32]. H2O2 pretreatment of human umbilical cord mesenchymal stem cells (UCMSCs) or human ADMSCs improved the ability of cells to resist high-dose H2O2-induced oxidative stress [33, 34]. In this study, we explored whether pretreating NPMSCs with H2O2 can improve the therapeutic efficacy of transplanted NPMSCs in IVDD and identified the optimal concentration. We found that 75 μM H2O2-pretreated NPMSCs demonstrated the strongest elevated cell proliferation, enhanced antioxidative stress ability, and distinctly reduced apoptosis. The in vivo experimental results verified that 75 μM H2O2-pretreated NPMSCs transplantation exhibited distinctly enhanced DHI%, better histological morphology, and higher survival. These results demonstrate that 75 μM H2O2 is an optimal concentration for facilitating the therapeutic potential of NPMSCs transplantation in IVDD treatment.

Stem cells reported to treat IVDD include induced pluripotent stem cells (iPSCs), BMMSCs, ADSCs, and NPMSCs [8, 13, 35]. NPMSCs are stem cells derived from nucleus pulposus tissue that is regarded as a more suitable candidate for transplantation in IVDD treatment. NPMSCs can survive better in the microenvironment of the degenerated intervertebral disc and replenish the residual nucleus pulposus cells [15, 35, 36]. Therefore, NPMSCs were selected as research objects in our study. NPMSCs were isolated from the nucleus pulposus tissue of rats. We observed that these cells could proliferate and grow adherent in a cell culture flask. In addition, these cells expressed CD34 and CD45 at low levels and CD73, CD90, and CD105 at high levels, consistent with the standardized cell surface markers of mesenchymal stem cells [37]. Furthermore, these cells could undergo trilineage differentiation. All of the above characteristics indicated that these cells fit the characteristics of mesenchymal stem cells [37].

To determine the optimal concentration of H2O2 for NPMSCs pretreatment, NPMSCs were cultured with different concentrations of H2O2 for 12 h according to the previous article reports [24]. First, the cell viability and cell proliferation of NPMSCs were detected. We found that 50 μM, 75 μM, and 100 μM H2O2 promoted the viability and proliferation of NPMSCs, while 200 μM H2O2 and 300 μM H2O2 inhibited the viability and proliferation of NPMSCs. Among the designated concentrations, 75 μM H2O2-treated NPMSCs exhibited the highest facilitating effects. Moreover, the expression of cyclin D1, reported as a cell proliferation facilitator [38, 39], as well as P16, a well-known cell cycle repressor [40], was detected to consolidate our results. Consistent with the above observations, we found that 75 μM H2O2-treated NPMSCs exhibited maximized expression of cyclin D1 and the lowest expression of P16, whereas the expression of cyclin D1 was decreased and the expression of P16 was elevated to the greatest extent in 300 μM H2O2-treated NPMSCs. Therefore, 75 μM was selected as the pretreatment concentration and 300 μM was selected as the concentration to induce inhibition of cell proliferation in subsequent experiments.

The Hippo pathway plays an important role in regulating stem cell proliferation and apoptosis [27, 41, 42]. Previous studies have shown that the activated Hippo pathway can inhibit cell proliferation and promote cell apoptosis of IVD cells [43,44,45,46]. Moreover, the inhibition of the Hippo pathway is closely related to H2O2-induced BMMSCs proliferation upregulation and apoptosis downregulation [47]. Therefore, the expression of key proteins in the Hippo pathway was detected to explore the mechanism by which H2O2 promotes NPMSCs proliferation. We found that 75 μM H2O2 treatment significantly reduced the phosphorylation of Lats1, Mst1, and YAP, indicating that the Hippo pathway was inhibited. However, when NPMSCs were pretreated with 300 μM H2O2, the phosphorylation of key proteins in this pathway decreased, indicating that 75 μM H2O2 pretreatment may promote NPMSCs proliferation by inhibiting the Hippo pathway to some extent.

Oxidative stress is one of the key factors leading to cell damage in the intervertebral disc. ROS generated by intracellular metabolism can cause mitochondrial homeostasis loss and induce cell death [48,49,50]. We found that with increasing H2O2 concentration, the intracellular ROS content increased gradually. However, we found that 75 μM H2O2-pretreated NPMSCs exhibited a distinct suppressed ROS level and upregulated MMP when they were supplemented with subsequent 300 μM H2O2. These outcomes indicate that NPMSCs can activate their own antioxidant system after pretreatment and thus reduce the content of ROS in cells when they encounter detrimental 300 μM H2O2. The Keap1-Nrf2 signalling pathway is the most important antioxidant system in cells. Activated Nrf2 can promote the expression of antioxidant factors such as NAD(P)H quinone dehydrogenase 1 (NQO1) and superoxide dismutase (SOD) [51,52,53,54]. Previous studies have shown that activating the Keap1-Nrf2 signalling pathway could protect IVD cells from oxidative stress injury [55, 56]. Therefore, we then explored whether the decreased ROS and increased MMP were associated with the activation of the Keap1-Nrf2 signalling pathway. Our results found that 75 μM pretreated H2O2 exhibited enhanced expression of Nrf2, and reduced expression of Keap1 when they were supplemented with subsequent 300 μM H2O2. As an upstream regulatory molecule of the Keap1-Nrf2 signalling pathway, Brd4 can inhibit the activation of this pathway and elevate intracellular oxidative stress [57, 58]. Interestingly, when NPMSCs were treated with 75 μM H2O2, Brd4 was also decreased. Therefore, we hypothesized that pretreatment with 75 μM H2O2 might regulate the Keap1-Nrf2 signalling pathway by regulating Brd4. Subsequently, we treated NPMSCs with the Brd4 inhibitor JQ-1. JQ-1-treated NPMSCs and 75 μM H2O2-pretreated NPMSCs exhibited similar changes in the expression levels of Brd4, Keap1, and Nrf2, which partially confirmed our hypothesis.

Meanwhile, the apoptotic rate of NPMSCs under different H2O2 concentrations was detected. We found that 75 μM H2O2-treated NPMSCs exhibited the lowest cell apoptotic rate, while 300 μM H2O2-treated NPMSCs exhibited the highest cell apoptotic rate. Moreover, 75 μM H2O2-pretreated NPMSCs exhibited a distinct suppressed cell apoptotic rate when they were supplemented with subsequent 300 μM H2O2. The ratio of the antiapoptotic protein Bcl-2 to the proapoptotic protein Bax is an important indicator of the degree of apoptosis mediated by the mitochondrial pathway [52, 59]. The level of cytochrome C is the gold standard for mitochondrial damage [60]. Therefore, the expression levels of Bcl-2, Bax, apoptotic marker cleaved caspase-3, and cytochrome C were detected. We found that 75 μM H2O2-treated NPMSCs demonstrated the highest ratio of Bcl-2 to Bax, and the lowest levels of cleaved caspase-3 and cytochrome C levels. The NPMSCs that received 300 μM H2O2 demonstrated the lowest ratio of Bcl-2 to Bax and the highest levels of cleaved caspase-3 and cytochrome C. However, NPMSCs supplemented with 300 μM H2O2 exhibited an elevated ratio of Bcl-2 to Bax and reduced levels of cleaved caspase-3 and cytochrome C levels if they were pretreated with 75 μM H2O2. These results suggest that pretreatment of NPMSCs with 75 μM H2O2 may enhance the ability of cells to resist apoptosis by stabilizing mitochondria. These beneficial effects may also partly be attributed to the effects of H2O2 on the Hippo pathway and Keap1-Nrf2 pathway.

The above experimental results indicate that pretreatment with 75 μM H2O2 for 12 h can significantly improve the antiapoptotic ability of NPMSCs. Further research will illuminate the underlying mechanisms by which H2O2 pretreatment regulates NPMSCs apoptosis. The signalling pathways involved in the regulation of cell proliferation, oxidative stress, and cell apoptosis by H2O2 are summarized in Fig. 7.

Fig. 7
figure 7

Signalling pathway involved in H2O2 regulation of cell proliferation, oxidative stress, and cell apoptosis in NPMSCs. The optimal concentration of H2O2 was 75 μM; the lethal concentration of H2O2 was 300 μM. Up arrow: upregulation. Down arrow: downregulation

Full size image

Based on the above in vitro study, we determined that 75 μM H2O2 pretreatment may maximize the proliferation and antiapoptotic ability of NPMSCs. Therefore, we further explored whether 75 μM H2O2 pretreatment NPMSCs could improve the therapeutic efficacy of NPMSCs transplantation in a rat IVDD model. As expected, compared to rats in other groups, rats injected with 75 μM H2O2-pretreated NPMSCs showed increased transplanted cell survival, facilitated extracellular matrix deposition, and a distinct improvement in DHI% during a 60-day observation. Therefore, these results confirmed that 75 μM H2O2 is an optimal concentration for NPMSCs’ pretreatment before transplantation. Notably, the optimal concentration of H2O2 pretreatment was slightly higher than the optimal concentration of previous studies [61, 62]. This discrepancy may be attributed to the intrinsic features of NPMSCs, which reside in a microenvironment of high mechanical pressure, low oxygen supplementation, and high lactic acid concentration. NPMSCs may innately possess a certain resistance to H2O2.

There are several limitations in our experiment. First, our experiment directly selected the time of H2O2 pretreatment reported before; thus, the relationship between the therapeutic effects of H2O2 and pretreatment time was not explored. A time gradient experiment will further explore the optimal invention time to maximize the facilitating effects of H2O2 in the future. In addition, the underlying mechanisms by which H2O2 pretreatment regulates the Hippo signalling pathway and Keap1-Nrf2 signalling pathway were not investigated in our current experiments, and further molecular-level understanding of the experimental observations needs to be explored in the future. However, the present experiments have proven the beneficial effects of 75 μM H2O2 in NPMSCs pretreatment. Given that this method is convenient and efficient, H2O2-pretreated NPMSCs transplantation may become a feasible method for treating IVDD clinically in the future.

Conclusions

In summary, we identified for the first time that pretreatment with 75 μM H2O2 can better promote cell proliferation and reduce oxidative stress and cell apoptosis in NPMSCs in vitro, which is related to the regulation of the Hippo signalling pathway and Keap1-Nrf2 pathway. NPMSCs pretreated with 75 μM H2O2 also exhibited the most satisfactory therapeutic effects when transplanted into rat degenerated caudal intervertebral discs. These results demonstrate that 75 μM H2O2 is an optimal concentration for NPMSCs pretreatment and may serve as a feasible method for the clinical application of NPMSCs-based therapy in treating IVDD in the future.

Availability of data and materials

All the data supporting the results were shown in the article and can be applicable from the corresponding author on reasonable request.

Abbreviations

IVDD:

Intervertebral disc degeneration

NPMSCs:

Nucleus pulposus mesenchymal stem cells

H2O2 :

Hydrogen peroxide

ROS:

Reactive oxygen species

MMP:

Mitochondrial membrane potential

Brd4:

Bromodomain-containing protein 4

Keap1:

Kelch-like ECH-associated protein 1

Nrf2:

Nuclear factor, erythroid-derived 2, like 2

BMMSCs:

Bone marrow mesenchymal stem cells

OD:

Optical density

GFP:

Green fluorescent protein

MOI:

Multiplicity of infection

CO6-7:

Coccyx 6–7

HE:

Haematoxylin–eosin

UCMSCs:

Umbilical cord mesenchymal stem cells

ADMSCs:

Adipose mesenchymal stem cells

iPSCs:

Induced pluripotent stem cells

P16:

Cyclin-dependent kinase inhibitor 2A

p-Lats1:

Phosphorylated large tumour suppressor kinase 1

p-Mst1:

Phosphorylated mercaptopyruvate sulfurtransferase-1

p-YAP:

Phosphorylated Yes1-associated transcriptional regulator

YAP:

Yes1-associated transcriptional regulator

TAZ:

Tafazzin

ARE:

Antioxidant response elements

NQO1:

NAD(P)H quinone dehydrogenase 1

SOD:

Superoxide dismutase

References

  1. Jöud A, Petersson IF, Englund M. Low back pain: epidemiology of consultations. Arthritis Care Res (Hoboken). 2012;64(7):1084–8. https://doi.org/10.1002/acr.21642.

    Article  Google Scholar 

  2. Martin BI, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299(6):656–64. https://doi.org/10.1001/jama.299.6.656.

    Article  CAS  PubMed  Google Scholar 

  3. Bowles RD, Setton LA. Biomaterials for intervertebral disc regeneration and repair. Biomaterials. 2017;129:54–67. https://doi.org/10.1016/j.biomaterials.2017.03.013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Raj PP. Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Pract Off J World Inst Pain. 2008;8(1):18–44. https://doi.org/10.1111/j.1533-2500.2007.00171.x.

    Article  Google Scholar 

  5. Lo WC, Tsai LW, Yang YS, Chan RWY. Understanding the future prospects of synergizing minimally invasive transforaminal lumbar interbody fusion surgery with ceramics and regenerative cellular therapies. Int J Mol Sci. 2021;22(7):3638. https://doi.org/10.3390/ijms22073638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chen BL, et al. Surgical versus non-operative treatment for lumbar disc herniation: a systematic review and meta-analysis. Clin Rehabil. 2018;32(2):146–60. https://doi.org/10.1177/0269215517719952.

    Article  PubMed  Google Scholar 

  7. Clouet J, Fusellier M, Camus A, Le Visage C, Guicheux J. Intervertebral disc regeneration: from cell therapy to the development of novel bioinspired endogenous repair strategies. Adv Drug Deliv Rev. 2019;146:306–24. https://doi.org/10.1016/j.addr.2018.04.017.

    Article  CAS  PubMed  Google Scholar 

  8. Matta A, Karim MZ, Gerami H, Benigno B, Erwin WM. A comparative study of mesenchymal stem cell transplantation and NTG-101 molecular therapy to treat degenerative disc disease. Sci Rep. 2021;11(1):14804. https://doi.org/10.1038/s41598-021-94173-w.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Yu C, et al. Injectable kartogenin and apocynin loaded micelle enhances the alleviation of intervertebral disc degeneration by adipose-derived stem cell. Bioact Mater. 2021;6(10):3568–79. https://doi.org/10.1016/j.bioactmat.2021.03.018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ma CJ, Liu X, Che L, Liu ZH, Samartzis D, Wang HQ. Stem cell therapies for intervertebral disc degeneration: immune privilege reinforcement by Fas/FasL regulating machinery. Curr Stem Cell Res Ther. 2015;10(4):285–95. https://doi.org/10.2174/1574888x10666150416114027.

    Article  CAS  PubMed  Google Scholar 

  11. Kregar Velikonja N, et al. Cell sources for nucleus pulposus regeneration. Eur Spine J Off Publ Eur Spine Soc Eur Spin Deform Soc Eur Sect Cerv Spine Res Soc. 2014;23(Suppl 3):S364–74. https://doi.org/10.1007/s00586-013-3106-9.

    Article  Google Scholar 

  12. Wang W, et al. Transplantation of hypoxic-preconditioned bone mesenchymal stem cells retards intervertebral disc degeneration via enhancing implanted cell survival and migration in rats. Stem Cells Int. 2018;2018:7564159. https://doi.org/10.1155/2018/7564159.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Yim RL, et al. A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics. Stem Cells Dev. 2014;23(21):2553–67. https://doi.org/10.1089/scd.2014.0203.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sakai D, Andersson GB. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions. Nat Rev Rheumatol. 2015;11(4):243–56. https://doi.org/10.1038/nrrheum.2015.13.

    Article  PubMed  Google Scholar 

  15. Han B, et al. Nucleus pulposus mesenchymal stem cells in acidic conditions mimicking degenerative intervertebral discs give better performance than adipose tissue-derived mesenchymal stem cells. Cells Tissues Organs. 2014;199(5–6):342–52. https://doi.org/10.1159/000369452.

    Article  CAS  PubMed  Google Scholar 

  16. Wu H, et al. Comparison of nucleus pulposus stem/progenitor cells isolated from degenerated intervertebral discs with umbilical cord derived mesenchymal stem cells. Exp Cell Res. 2017;361(2):324–32. https://doi.org/10.1016/j.yexcr.2017.10.034.

    Article  CAS  PubMed  Google Scholar 

  17. Li Z, et al. Comparison of different methods for the isolation and purification of rat nucleus pulposus-derived mesenchymal stem cells. Connect Tissue Res. 2020;61(5):426–34. https://doi.org/10.1080/03008207.2019.1611793.

    Article  PubMed  Google Scholar 

  18. Bartels EM, Fairbank JC, Winlove CP, Urban JP. Oxygen and lactate concentrations measured in vivo in the intervertebral discs of patients with scoliosis and back pain. Spine. 1998;23(1):1–7. https://doi.org/10.1097/00007632-199801010-00001.

    Article  CAS  PubMed  Google Scholar 

  19. Grunhagen T, Wilde G, Soukane DM, Shirazi-Adl SA, Urban JP. Nutrient supply and intervertebral disc metabolism. J Bone Joint Surg Am. 2006;88(Suppl 2):30–5. https://doi.org/10.2106/jbjs.E.01290.

    Article  PubMed  Google Scholar 

  20. Rudert M, Tillmann B. Lymph and blood supply of the human intervertebral disc. Cadaver study of correlations to discitis. Acta Orthop Scand. 1993;64(1):37–40. https://doi.org/10.3109/17453679308994524.

    Article  CAS  PubMed  Google Scholar 

  21. Xing H, et al. Injectable exosome-functionalized extracellular matrix hydrogel for metabolism balance and pyroptosis regulation in intervertebral disc degeneration. J Nanobiotechnol. 2021;19(1):264. https://doi.org/10.1186/s12951-021-00991-5.

    Article  CAS  Google Scholar 

  22. Zeng Y, et al. Injectable microcryogels reinforced alginate encapsulation of mesenchymal stromal cells for leak-proof delivery and alleviation of canine disc degeneration. Biomaterials. 2015;59:53–65. https://doi.org/10.1016/j.biomaterials.2015.04.029.

    Article  CAS  PubMed  Google Scholar 

  23. Colella F, et al. Drug delivery in intervertebral disc degeneration and osteoarthritis: selecting the optimal platform for the delivery of disease-modifying agents. J Controll Release Off J Controll Release Soc. 2020;328:985–99. https://doi.org/10.1016/j.jconrel.2020.08.041.

    Article  CAS  Google Scholar 

  24. Guo L, et al. Optimal H2O2 preconditioning to improve bone marrow mesenchymal stem cells’ engraftment in wound healing. Stem Cell Res Ther. 2020. https://doi.org/10.1186/s13287-020-01910-5.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Liao N, et al. Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model. Stem Cell Res Ther. 2020;11(1):237. https://doi.org/10.1186/s13287-020-01763-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Zhang J, et al. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton’s Jelly mesenchymal stem cells after myocardial infarction. Chin Med J. 2012;125(19):3472–8.

    CAS  PubMed  Google Scholar 

  27. Chi X, et al. Protective effect of epigallocatechin-3-gallate in hydrogen peroxide-induced oxidative damage in chicken lymphocytes. Oxid Med Cell Longev. 2020;2020:7386239. https://doi.org/10.1155/2020/7386239.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Nakayama H, et al. Protective effect of ferulic acid against hydrogen peroxide induced apoptosis in PC12 cells. Molecules (Basel, Switzerland). 2020. https://doi.org/10.3390/molecules26010090.

    Article  PubMed Central  Google Scholar 

  29. Han B, et al. A simple disc degeneration model induced by percutaneous needle puncture in the rat tail. Spine. 2008;33(18):1925–34. https://doi.org/10.1097/BRS.0b013e31817c64a9.

    Article  PubMed  Google Scholar 

  30. Zhu J, et al. Sustained release of GDF5 from a designed coacervate attenuates disc degeneration in a rat model. Acta Biomater. 2019;86:300–11. https://doi.org/10.1016/j.actbio.2019.01.028.

    Article  CAS  PubMed  Google Scholar 

  31. Binch ALA, Fitzgerald JC, Growney EA, Barry F. Cell-based strategies for IVD repair: clinical progress and translational obstacles. Nat Rev Rheumatol. 2021;17(3):158–75. https://doi.org/10.1038/s41584-020-00568-w.

    Article  PubMed  Google Scholar 

  32. Li S, Deng Y, Feng J, Ye W. Oxidative preconditioning promotes bone marrow mesenchymal stem cells migration and prevents apoptosis. Cell Biol Int. 2009;33(3):411–8. https://doi.org/10.1016/j.cellbi.2009.01.012.

    Article  CAS  PubMed  Google Scholar 

  33. Garrido-Pascual P, Alonso-Varona A, Castro B, Buron M, Palomares T. H2O2-preconditioned human adipose-derived stem cells (HC016) increase their resistance to oxidative stress by overexpressing Nrf2 and bioenergetic adaptation. Stem Cell Res Ther. 2020;11(1):335. https://doi.org/10.1186/s13287-020-01851-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Li D, Xu Y, Gao CY, Zhai YP. Adaptive protection against damage of preconditioning human umbilical cord-derived mesenchymal stem cells with hydrogen peroxide. Genet Mol Res GMR. 2014;13(3):7304–17. https://doi.org/10.4238/2014.February.21.9.

    Article  CAS  PubMed  Google Scholar 

  35. Tao YQ, et al. Potential of co-culture of nucleus pulposus mesenchymal stem cells and nucleus pulposus cells in hyperosmotic microenvironment for intervertebral disc regeneration. Cell Biol Int. 2013;37(8):826–34. https://doi.org/10.1002/cbin.10110.

    Article  CAS  PubMed  Google Scholar 

  36. Liu J, et al. Biological behavior of human nucleus pulposus mesenchymal stem cells in response to changes in the acidic environment during intervertebral disc degeneration. Stem Cells Dev. 2017;26(12):901–11. https://doi.org/10.1089/scd.2016.0314.

    Article  CAS  PubMed  Google Scholar 

  37. Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315–7. https://doi.org/10.1080/14653240600855905.

    Article  CAS  PubMed  Google Scholar 

  38. Rahman MM, et al. Differential expression of phosphorylated MEK and ERK correlates with aggressive BCC subtypes. Carcinogenesis. 2021;42(7):975–83. https://doi.org/10.1093/carcin/bgab036.

    Article  CAS  PubMed  Google Scholar 

  39. Guo Y, Zhao N, Zhou J, Dong J, Wang X. Sirtuin 2 in endometrial cancer: a potential regulator for cell proliferation, apoptosis and RAS/ERK pathway. Technol Cancer Res Treat. 2020. https://doi.org/10.1177/1533033820980781.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Childs BG, et al. Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov. 2017;16(10):718–35. https://doi.org/10.1038/nrd.2017.116.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Nguyen-Lefebvre AT, Selzner N, Wrana JL, Bhat M. The hippo pathway: a master regulator of liver metabolism, regeneration, and disease. FASEB J. 2021;35(5):e21570. https://doi.org/10.1096/fj.202002284RR.

    Article  CAS  PubMed  Google Scholar 

  42. Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13(8):877–83. https://doi.org/10.1038/ncb2303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Croft AS, Roth Y, Oswald KAC, Ćorluka S, Bermudez-Lekerika P, Gantenbein B. In situ cell signalling of the hippo-YAP/TAZ pathway in reaction to complex dynamic loading in an intervertebral disc organ culture. Int J Mol Sci. 2021;22(24):13641. https://doi.org/10.3390/ijms222413641.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Yang H, et al. LncRNA JPX regulates proliferation and apoptosis of nucleus pulposus cells by targeting the miR-18a-5p/HIF-1alpha/Hippo-YAP pathway. Biochem Biophys Res Commun. 2021;566:16–23. https://doi.org/10.1016/j.bbrc.2021.05.075.

    Article  CAS  PubMed  Google Scholar 

  45. Wang Y, et al. Hydrostatic pressure modulates intervertebral disc cell survival and extracellular matrix homeostasis via regulating hippo-YAP/TAZ pathway. Stem Cells Int. 2021;2021:5626487. https://doi.org/10.1155/2021/5626487.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Chen J, et al. IL-6/YAP1/beta-catenin signaling is involved in intervertebral disc degeneration. J Cell Physiol. 2019;234(5):5964–71. https://doi.org/10.1002/jcp.27065.

    Article  CAS  PubMed  Google Scholar 

  47. Jeon S, Kim D, Cho J. Neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) regulates hydrogen peroxide-induced cell proliferation and death through inhibition of Hippo signaling. FASEB J Off Publ Fed Am Soc Exp Biol. 2019;33(12):14772–83. https://doi.org/10.1096/fj.201901404R.

    Article  CAS  Google Scholar 

  48. Hu Y, et al. Exosomes derived from bone mesenchymal stem cells alleviate compression-induced nucleus pulposus cell apoptosis by inhibiting oxidative stress. Oxid Med Cell Longev. 2021;2021:2310025. https://doi.org/10.1155/2021/2310025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Foo BJ, Eu JQ, Hirpara JL, Pervaiz S. Interplay between mitochondrial metabolism and cellular redox state dictates cancer cell survival. Oxid Med Cell Longev. 2021;2021:1341604. https://doi.org/10.1155/2021/1341604.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Di Meo S, Reed TT, Venditti P, Victor VM. Role of ROS and RNS sources in physiological and pathological conditions. Oxid Med Cell Longev. 2016;2016:1245049. https://doi.org/10.1155/2016/1245049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Yu C, Xiao JH. The Keap1-Nrf2 system: a mediator between oxidative stress and aging. Oxid Med Cell Longev. 2021;2021:6635460. https://doi.org/10.1155/2021/6635460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Xiao Q, Piao R, Wang H, Li C, Song L. Orientin-mediated Nrf2/HO-1 signal alleviates H(2)O(2)-induced oxidative damage via induction of JNK and PI3K/AKT activation. Int J Biol Macromol. 2018;118(1):747–55. https://doi.org/10.1016/j.ijbiomac.2018.06.130.

    Article  CAS  PubMed  Google Scholar 

  53. Schmidlin CJ, Dodson MB, Madhavan L, Zhang DD. Redox regulation by NRF2 in aging and disease. Free Radic Biol Med. 2019;134:702–7. https://doi.org/10.1016/j.freeradbiomed.2019.01.016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Dayalan Naidu S, Kostov RV, Dinkova-Kostova AT. Transcription factors Hsf1 and Nrf2 engage in crosstalk for cytoprotection. Trends Pharmacol Sci. 2015;36(1):6–14. https://doi.org/10.1016/j.tips.2014.10.011.

    Article  CAS  PubMed  Google Scholar 

  55. Hua W, et al. Icariin protects human nucleus pulposus cells from hydrogen peroxide-induced mitochondria-mediated apoptosis by activating nuclear factor erythroid 2-related factor 2. Biochim Biophys Acta Mol Basis Dis. 2020;1866(1):165575. https://doi.org/10.1016/j.bbadis.2019.165575.

    Article  CAS  PubMed  Google Scholar 

  56. Zhu H, et al. Dimethyl fumarate protects nucleus pulposus cells from inflammation and oxidative stress and delays the intervertebral disc degeneration. Exp Ther Med. 2020;20(6):269. https://doi.org/10.3892/etm.2020.9399.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Hussong M, et al. The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response. Cell Death Dis. 2014;5:e1195. https://doi.org/10.1038/cddis.2014.157.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Zuo H, Wang S, Feng J, Liu X. BRD4 contributes to high-glucose-induced podocyte injury by modulating Keap1/Nrf2/ARE signaling. Biochimie. 2019;165:100–7. https://doi.org/10.1016/j.biochi.2019.07.012.

    Article  CAS  PubMed  Google Scholar 

  59. Dadsena S, King LE, García-Sáez AJ. Apoptosis regulation at the mitochondria membrane level. Biochim Biophys Acta Biomembr. 2021;1863(12):183716. https://doi.org/10.1016/j.bbamem.2021.183716.

    Article  CAS  PubMed  Google Scholar 

  60. Ma K, Chen G, Li W, Kepp O, Zhu Y, Chen Q. Mitophagy, mitochondrial homeostasis, and cell fate. Front Cell Dev Biol. 2020;8:467. https://doi.org/10.3389/fcell.2020.00467.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Khatlani T, et al. Preconditioning by hydrogen peroxide enhances multiple properties of human decidua basalis mesenchymal stem/multipotent stromal cells. Stem Cells Int. 2018;2018:6480793. https://doi.org/10.1155/2018/6480793.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Pendergrass KD, et al. Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury. Stem Cells Dev. 2013;22(17):2414–24. https://doi.org/10.1089/scd.2012.0673.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Mr. Yang Zhang in our laboratory for technical assistance. Also, we thank all the peer reviewers for their opinions and suggestions.

Funding

This research was supported by the National Natural Science Foundation of China (Grant No. 81972113 and 82172488).

Author information

Authors and Affiliations

  1. Department of Orthopedics, Xinqiao Hospital, Army Military Medical University, Chongqing, 400037, China

    Yu-yao Zhang, Zhi-lei Hu, Hai-yin Li, Xian Chang, Xiao-xin Gao, Chen-hao Liu, Yue-yang Li, Jin-hui Lou, Yu Zhai & Chang-qing Li

  2. Institute of Basic Theory of Traditional Chinese Medicine, China Academy of Chinese Medical Science, Beijing, 100000, China

    Yu-han Qi

Authors
  1. Yu-yao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhi-lei Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-han Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hai-yin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xian Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiao-xin Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chen-hao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yue-yang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jin-hui Lou
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yu Zhai
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Chang-qing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZYY and LCQ conceived and designed the experiments; ZYY and HZL performed the experiments; GXX and LCH participated in the creation of the experimental animal model. LHY and CX revised the article and conducted the experiments complementation; ZY and LYY analysed the data; ZYY and LJH edited the figures; LCQ polished the language. ZYY, ZY, and QYH wrote this article. LCQ and ZY reviewed and edited the article. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Yu Zhai or Chang-qing Li.

Ethics declarations

Ethics approval and consent to participate

Ethics approval was obtained with the informed consent of all participants. The Ethics Committee of the Army Medical University approved this research (No. AMUWEC20212130).

Consent for publication

All authors approved the manuscript, and their written informed consent for publication was obtained.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Fig. S1.

Flow chart and timetable of rat NPMSCs treatment process. Group A was pretreatment group; Group B was unpretreatment group.

Additional file 2: Table S1

. Histological grading scale of the disc degeneration.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Yy., Hu, Zl., Qi, Yh. et al. Pretreatment of nucleus pulposus mesenchymal stem cells with appropriate concentration of H2O2 enhances their ability to treat intervertebral disc degeneration. Stem Cell Res Ther 13, 340 (2022). https://doi.org/10.1186/s13287-022-03031-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13287-022-03031-7

Keywords

Stem Cell Research & Therapy

ISSN: 1757-6512